S&P 500 7,500.58 ▲ 80.48 (+1.08%) DOW 51,564.70 ▲ 72.15 (+0.14%) NASDAQ 26,517.93 ▲ 496.28 (+1.91%) US Markets Closed â€ĸ 08:16 PM ET

SNWV

SANUWAVE Health, Inc.

Price Chart
Latest Quote

$9.21

+0.12 (+1.32%)
Current Price
Previous Close $9.09
Open $9.15
Day High $9.69
Day Low $8.75
Volume 284,923
Fetched: 2026-06-20T00:16:53
Stock Information
Shares Outstanding 8.60M
Total Debt $22.16M
Cash Equivalents $10.78M
Revenue $44.34M
Net Income $16.49M
Sector Healthcare
Industry Medical Devices
Market Cap $79.20M
P/E Ratio 9.59
EPS (TTM) $0.96
Exchange NGM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$84.56M
Sales$44.34M
Income$16.49M
Book/sh$0.19
Cash/sh$1.25
Employees55
Financial Ratios
Quick Ratio0.92
Current Ratio1.31
Debt/Eq1205.88
Returns & Margins
ROA8.81%
Gross Margin76.74%
Operating Margin-11.68%
Profit Margin37.20%
Ownership
Insider Ownership1.31%
Institutional Ownership47.23%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-921.00
P/S1.79
P/B48.99
Analyst Data
Recommendationnone
Technical Indicators
SMA20$14.53
SMA50$16.28
SMA200$25.88
RSI16.20
ATR1.3686
Shares Float5.79M
Short Float13.70%
Short Ratio6.89
Volatility1.34
Rel Volume1.89
Performance History
Week-37.30%
Month-44.82%
Quarter-55.12%
6 Months-70.72%
YTD-68.12%
Year-69.19%
10 Years-29.29%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-18 $9.21 290,700
2026-06-17 $9.09 555,800
2026-06-16 $8.51 1,039,500
2026-06-15 $14.67 73,700
2026-06-12 $14.91 77,100
2026-06-11 $14.69 79,200
2026-06-10 $14.38 57,800
2026-06-09 $14.52 38,600
2026-06-08 $14.55 78,100
2026-06-05 $14.76 55,400
2026-06-04 $15.39 110,300
2026-06-03 $15.60 73,000
2026-06-02 $15.09 63,700
2026-06-01 $15.85 53,200
2026-05-29 $16.47 49,300
2026-05-28 $16.66 83,500
2026-05-27 $16.31 74,400
2026-05-26 $16.26 77,600
2026-05-22 $16.69 93,900
2026-05-21 $17.00 51,500
2026-05-20 $16.75 75,000
2026-05-19 $16.69 51,700
About SANUWAVE Health, Inc.

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Period:
Loading...
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Reconciled Cost Of Revenue $9,679,000 $7,728,000 $5,759,000 $4,145,000
Cost Of Revenue $10,082,000 $8,084,000 $6,035,000 $4,331,000
Total Revenue $44,051,000 $32,634,000 $20,398,000 $16,742,000
Operating Revenue $44,051,000 $32,634,000 $20,398,000 $16,742,000
Expenses
Interest Expense $6,246,000 $13,779,000 $15,623,000 $14,132,000
Total Expenses $39,106,000 $28,786,000 $20,938,000 $25,694,000
Other Income Expense $13,200,000 $-23,125,000 $-9,640,000 $16,227,000
Other Non Operating Income Expenses $5,766,000 $1,962,000 $-19,000 $-9,000
Net Non Operating Interest Income Expense $-6,246,000 $-13,779,000 $-15,623,000 $-17,566,000
Interest Expense Non Operating $6,246,000 $13,779,000 $15,623,000 $14,132,000
Operating Expense $29,024,000 $20,702,000 $14,903,000 $21,363,000
Selling And Marketing Expense $7,419,000 $6,323,000 $4,898,000 $7,474,000
General And Administrative Expense $19,372,000 $12,917,000 $8,674,000 $12,556,000
Total Other Finance Cost - - - $3,434,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Net Interest Income $-6,246,000 $-13,779,000 $-15,623,000 $-17,566,000
Normalized Income $4,431,038 $-13,264,270 $-18,206,410 $-23,119,440
Net Income From Continuing And Discontinued Operation $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Total Operating Income As Reported $4,945,000 $3,848,000 $-540,000 $-8,952,000
Net Income Common Stockholders $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Net Income $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Net Income Including Noncontrolling Interests $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Net Income Continuous Operations $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Pretax Income $11,899,000 $-33,056,000 $-25,803,000 $-10,291,000
Special Income Charges $-673,000 $6,326,000 $0 $-418,000
Operating Income $4,945,000 $3,848,000 $-540,000 $-8,952,000
Depreciation Amortization Depletion Income Statement $880,000 $789,000 $752,000 $766,000
Depreciation And Amortization In Income Statement $880,000 $789,000 $752,000 $766,000
Depreciation Income Statement $880,000 $789,000 $752,000 $766,000
Gross Profit $33,969,000 $24,550,000 $14,363,000 $12,411,000
Per Share
Diluted EPS $0.41 $-7.03 $-12.19 $-7.50
Basic EPS $1.38 $-7.03 $-12.19 $-7.50
Other
Tax Effect Of Unusual Items $52,038 $-5,268,270 $-2,020,410 $3,409,560
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $11,994,000 $6,955,000 $469,000 $-11,443,000
Total Unusual Items $7,434,000 $-25,087,000 $-9,621,000 $16,236,000
Total Unusual Items Excluding Goodwill $7,434,000 $-25,087,000 $-9,621,000 $16,236,000
Reconciled Depreciation $1,283,000 $1,145,000 $1,028,000 $952,000
EBITDA (Bullshit earnings) $19,428,000 $-18,132,000 $-9,152,000 $4,793,000
EBIT $18,145,000 $-19,277,000 $-10,180,000 $3,841,000
Diluted Average Shares $9,082,510 $4,462,883 $2,116,936 $1,465,255
Basic Average Shares $8,563,510 $4,462,883 $2,116,936 $1,465,255
Diluted NI Availto Com Stockholders $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Tax Provision $86,000 $27,000 $4,000 $2,000
Other Special Charges $477,000 $-6,326,000 - $418,000
Impairment Of Capital Assets $196,000 $0 - -
Gain On Sale Of Security $8,107,000 $-31,413,000 $-9,621,000 $16,654,000
Research And Development $1,353,000 $673,000 $579,000 $567,000
Selling General And Administration $26,791,000 $19,240,000 $13,572,000 $20,030,000
Other Gand A $19,372,000 $12,917,000 $8,674,000 $12,556,000
Fetched: 2026-06-17
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $-8,667,000 $-26,785,000 $-54,872,000 $-53,407,000
Total Assets $37,343,000 $30,119,000 $22,416,000 $19,873,000
Total Non Current Assets $12,716,000 $11,722,000 $12,632,000 $13,253,000
Other Non Current Assets $68,000 - - $106,000
Goodwill And Other Intangible Assets $10,286,000 $10,990,000 $11,694,000 $12,397,000
Other Intangible Assets $3,026,000 $3,730,000 $4,434,000 $5,137,000
Current Assets $24,627,000 $18,397,000 $9,784,000 $6,620,000
Other Current Assets $1,312,000 $682,000 $1,722,000 $570,000
Inventory $5,934,000 $4,149,000 $2,951,000 $868,000
Receivables $5,422,000 $3,329,000 $3,314,000 $4,029,000
Accounts Receivable $5,422,000 $3,329,000 $3,314,000 $4,029,000
Allowance For Doubtful Accounts Receivable $-1,265,000 $-1,147,000 $-1,237,000 $-1,037,000
Gross Accounts Receivable $6,687,000 $4,476,000 $4,551,000 $5,066,000
Cash Cash Equivalents And Short Term Investments $11,959,000 $10,237,000 $1,797,000 $1,153,000
Cash And Cash Equivalents $11,959,000 $10,237,000 $1,797,000 $1,153,000
Cash Financial - $10,237,000 $1,797,000 $1,153,000
Prepaid Assets - - - -
Debt
Net Debt $10,001,000 $15,068,000 $28,165,000 $37,385,000
Total Debt $22,971,000 $25,797,000 $30,454,000 $38,976,000
Long Term Debt And Capital Lease Obligation $17,176,000 $191,000 $492,000 $438,000
Long Term Debt $16,322,000 - - -
Current Debt And Capital Lease Obligation $5,795,000 $25,606,000 $29,962,000 $38,538,000
Current Debt $5,638,000 $25,305,000 $29,962,000 $38,538,000
Other Current Borrowings $5,638,000 - $7,109,000 $24,122,000
Liabilities
Total Liabilities Net Minority Interest $35,724,000 $45,914,000 $65,594,000 $60,883,000
Total Non Current Liabilities Net Minority Interest $17,877,000 $491,000 $839,000 $668,000
Non Current Deferred Liabilities $701,000 $300,000 $347,000 $230,000
Current Liabilities $17,847,000 $45,423,000 $64,755,000 $60,215,000
Other Current Liabilities $7,000 $8,140,000 $16,884,000 $3,865,000
Current Deferred Liabilities $388,000 $193,000 $92,000 $60,000
Current Notes Payable $0 $25,305,000 $22,853,000 $14,416,000
Payables And Accrued Expenses $10,437,000 $9,252,000 $15,519,000 $13,167,000
Interest Payable $24,000 $0 $6,113,000 $4,840,000
Payables $8,171,000 $6,806,000 $5,705,000 $4,400,000
Other Payable $32,000 $44,000 - -
Total Tax Payable $4,920,000 $3,078,000 - -
Accounts Payable $3,219,000 $3,684,000 $5,705,000 $4,400,000
Non Current Deferred Taxes Liabilities - - - $28,000
Equity
Common Stock Equity $1,619,000 $-15,795,000 $-43,178,000 $-41,010,000
Total Equity Gross Minority Interest $1,619,000 $-15,795,000 $-43,178,000 $-41,010,000
Stockholders Equity $1,619,000 $-15,795,000 $-43,178,000 $-41,010,000
Gains Losses Not Affecting Retained Earnings $10,000 $10,000 $-111,000 $-67,000
Other Equity Adjustments $10,000 $10,000 $-111,000 $-67,000
Retained Earnings $-242,685,000 $-254,499,000 $-220,049,000 $-194,242,000
Other
Ordinary Shares Number $8,588,876 $8,543,686 $3,041,492 $1,463,300
Share Issued $8,588,876 $8,543,686 $3,041,492 $1,463,300
Tangible Book Value $-8,667,000 $-26,785,000 $-54,872,000 $-53,407,000
Invested Capital $23,579,000 $9,510,000 $-13,216,000 $-2,472,000
Working Capital $6,780,000 $-27,026,000 $-54,971,000 $-53,595,000
Capital Lease Obligations $1,011,000 $492,000 $492,000 $438,000
Total Capitalization $17,941,000 $-15,795,000 $-43,178,000 $-41,010,000
Additional Paid In Capital $244,285,000 $238,685,000 $176,979,000 $152,750,000
Capital Stock $9,000 $9,000 $3,000 $549,000
Common Stock $9,000 $9,000 $3,000 $549,000
Preferred Stock $0 $0 $0 $0
Non Current Deferred Revenue $701,000 $300,000 $347,000 $230,000
Long Term Capital Lease Obligation $854,000 $191,000 $492,000 $438,000
Current Deferred Revenue $388,000 $193,000 $92,000 $60,000
Current Capital Lease Obligation $157,000 $301,000 - -
Pensionand Other Post Retirement Benefit Plans Current $1,220,000 $2,232,000 $2,298,000 $4,585,000
Current Accrued Expenses $2,266,000 $2,446,000 $9,814,000 $8,767,000
Goodwill $7,260,000 $7,260,000 $7,260,000 $7,260,000
Net PPE $2,362,000 $732,000 $938,000 $856,000
Accumulated Depreciation $-358,000 $-460,000 - -
Gross PPE $2,720,000 $1,192,000 - $750,000
Other Properties $1,413,000 $460,000 - $750,000
Machinery Furniture Equipment $1,307,000 $732,000 - -
Inventories Adjustments Allowances $-213,000 $-369,000 $-347,000 $-343,000
Finished Goods $6,012,000 $755,000 $416,000 $570,000
Raw Materials $135,000 $3,763,000 $2,535,000 $641,000
Fetched: 2026-06-17
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $1,934,000 $1,965,000 $-4,538,000 $-17,169,000
Operating Activities
Operating Cash Flow $3,876,000 $2,455,000 $-4,538,000 $-17,169,000
Cash Flow From Continuing Operating Activities $3,876,000 $2,455,000 $-4,538,000 $-17,169,000
Operating Gains Losses $-12,795,000 $25,087,000 $9,621,000 $-16,236,000
Investing Activities
Capital Expenditure $-1,942,000 $-490,000 - -
Investing Cash Flow $3,433,000 $-490,000 $21,000 $332,000
Cash Flow From Continuing Investing Activities $3,433,000 $-490,000 $21,000 $332,000
Financing Activities
Issuance Of Capital Stock $0 $10,300,000 $0 -
Financing Cash Flow $-5,587,000 $6,354,000 $5,211,000 $17,384,000
Cash Flow From Continuing Financing Activities $-5,587,000 $6,354,000 $5,211,000 $17,384,000
Net Other Financing Charges $-371,000 $-1,490,000 $-639,000 $695,000
Net Common Stock Issuance $0 $10,300,000 $0 -
Common Stock Issuance $0 $10,300,000 $0 -
Net Preferred Stock Issuance - - - -
Preferred Stock Issuance - - - -
Other
Repayment Of Debt $-29,427,000 $-4,256,000 $-170,000 $-3,218,000
Issuance Of Debt $23,655,000 $1,800,000 $6,020,000 $19,807,000
Interest Paid Supplemental Data $3,744,000 $4,311,000 $1,958,000 $3,712,000
Income Tax Paid Supplemental Data $27,000 $4,000 - -
End Cash Position $11,959,000 $10,237,000 $1,797,000 $1,153,000
Beginning Cash Position $10,237,000 $1,797,000 $1,153,000 $619,000
Effect Of Exchange Rate Changes $0 $121,000 $-50,000 $-13,000
Changes In Cash $1,722,000 $8,319,000 $694,000 $547,000
Proceeds From Stock Option Exercised $556,000 $0 $0 $100,000
Net Issuance Payments Of Debt $-5,772,000 $-2,456,000 $5,850,000 $16,589,000
Net Short Term Debt Issuance $-27,747,000 $-2,248,000 $6,020,000 $16,867,000
Short Term Debt Payments $-27,747,000 $-4,048,000 $0 -
Short Term Debt Issuance $0 $1,800,000 $6,020,000 $16,867,000
Net Long Term Debt Issuance $21,975,000 $-208,000 $-170,000 $-278,000
Long Term Debt Payments $-1,680,000 $-208,000 $-170,000 $-3,218,000
Long Term Debt Issuance $23,655,000 $0 $0 $2,940,000
Net Intangibles Purchase And Sale $5,375,000 $0 - -
Sale Of Intangibles $5,375,000 $0 - -
Net PPE Purchase And Sale $-1,942,000 $-490,000 $21,000 $332,000
Purchase Of PPE $-1,942,000 $-490,000 $0 -
Change In Working Capital $-4,015,000 $-1,192,000 $-3,606,000 $-1,119,000
Change In Other Current Liabilities $-156,000 $0 - -
Change In Payables And Accrued Expense $1,444,000 $571,000 $-547,000 $701,000
Change In Accrued Expense $1,965,000 $1,993,000 $-2,093,000 $3,251,000
Change In Payable $-521,000 $-1,422,000 $1,546,000 $-2,550,000
Change In Account Payable $-521,000 $-1,422,000 $1,546,000 $-2,550,000
Change In Prepaid Assets $-724,000 $-79,000 $-206,000 -
Change In Inventory $-2,283,000 $-1,198,000 $-2,800,000 $-72,000
Change In Receivables $-2,296,000 $-486,000 $-53,000 $-1,748,000
Changes In Account Receivables $-2,296,000 $-486,000 $-53,000 $-1,748,000
Other Non Cash Items $2,040,000 $8,907,000 $13,441,000 $9,272,000
Stock Based Compensation $4,850,000 $1,514,000 $0 -
Provisionand Write Offof Assets $202,000 $77,000 $781,000 $253,000
Asset Impairment Charge $498,000 $0 $781,000 $253,000
Depreciation Amortization Depletion $1,283,000 $1,145,000 $1,028,000 $952,000
Depreciation And Amortization $1,283,000 $1,145,000 $1,028,000 $952,000
Depreciation $1,283,000 $1,145,000 $1,028,000 $952,000
Gain Loss On Investment Securities $-8,107,000 $31,413,000 $9,621,000 $-16,654,000
Gain Loss On Sale Of PPE $-5,375,000 $0 - -
Net Income From Continuing Operations $11,813,000 $-33,083,000 $-25,807,000 $-10,293,000
Sale Of PPE - $0 $21,000 $332,000
Deferred Tax - $0 $4,000 $2,000
Deferred Income Tax - $0 $4,000 $2,000
Change In Interest Payable - - $6,306,000 $3,182,000
Net Business Purchase And Sale - - - -
Purchase Of Business - - - -
Change In Other Working Capital - - - -
Change In Other Current Assets - - - -
Amortization Cash Flow - - - -
Amortization Of Intangibles - - - -
Fetched: 2026-06-17